Stock Screener App

無料 -

インストール

21.19

3.11% 0.64

after-market

アフターアワーズ： 21.16 -0.03 -0.14%

First Tracks Biotherapeutics Inc (TRAX)

概要ニュース株価時系列ディスカッション予測

First Tracks Biotherapeutics Inc (TRAX) 最新ニュース

This First Tracks Biotherapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday - Sahm

First Tracks Price Target Announced at $54.00/Share by Piper Sandler - Moomoo

First Tracks Initiated at Overweight by Piper Sandler - Moomoo

This First Tracks Biotherapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations F - Benzinga

Piper Sandler initiates First Tracks stock with overweight rating By Investing.com - Investing.com Nigeria

Net income of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

First Tracks Biotherapeutics Inc (TRAX) Stock Price, Quote, News & History - Benzinga

TRAX Price History for First Tracks Biotherapeutics Stock - Barchart

Number of employees of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

What is the current Price Target and Forecast for First Tracks Biotherapeutics, Inc. (TRAX) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Earnings Yield (TTM) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Total Assets (Quarterly) - Zacks Investment Research

H.C. Wainwright Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $30 - Moomoo

First Tracks Biotherapeutics, Inc. (TRAX) Price To Cash Flow - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Total Expenses (Quarterly) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Revenue (Quarterly) Yoy Growth - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Total Long Term Debt (Quarterly) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Price To Free Cash Flow - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Net Income (Quarterly) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Cash Equivalents (Quarterly) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Total Liabilities - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Free Cash Flow (TTM) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Total Expenses (TTM) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Eps Diluted - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Book Value - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Shareholders Equity (Quarterly) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Free Cash Flow (Quarterly) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Cash From Investing (TTM) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Revenue (TTM) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Enterprise Value - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Gross Profit (TTM) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Gross Margin (TTM) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Revenue (Quarterly) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Cash From Operations (Quarterly) - Zacks Investment Research

First Tracks Biotherapeutics, Inc. (TRAX) Market Cap - Zacks Investment Research

This Micron Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

HC Wainwright Initiates First Tracks Biotherapeutics at Buy - marketscreener.com

H.C. Wainwright initiates First Tracks stock with buy rating By Investing.com - Investing.com Canada

AnaptysBio Completes Spin-Off of First Tracks Biotherapeutics: Key Financial Impacts and Pro Forma Results - Minichart

First Tracks Biotherapeutics, Inc. Financial Statements – NASDAQ:TRAX - TradingView

Price to earnings ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

First Tracks Biotherapeutics, Inc. Statistics – NASDAQ:TRAX - TradingView

First Tracks Biotherapeutics, Inc. Revenue Breakdown – NASDAQ:TRAX - TradingView

Anaptysbio’s spinout First Tracks hits the slopes - BioWorld News

AnaptysBio rises after completing First Tracks spinoff - MSN

Leerink Partners Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $46 - Moomoo

First Tracks Biotherapeutics, Inc. Dividends – NASDAQ:TRAX - TradingView

First Tracks Biotherapeutics, Inc. Income Statement – NASDAQ:TRAX - TradingView

Basic earnings per share (basic EPS) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Spin-off leaves AnaptysBio (NASDAQ: ANAB) with 2025 pro forma profit - Stock Titan

JPMorgan Initiates Coverage on First Tracks Biotherapeutics With Overweight Rating - marketscreener.com

TRAXV SEC FilingsFirst Tracks Biotherapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

JPMorgan initiates First Tracks Biotherapeutics stock at Overweight By Investing.com - Investing.com Canada

TRAX: First Tracks Biotherapeutics, Inc.Full Company Report - Zacks Investment Research

EcoR1, O. Nodelman disclose 9.1% stake in First Tracks (OTC: TRAXV) - Stock Titan

First Tracks (TRAXV) CBO Benjamin Stone details Form 3 equity stakes - Stock Titan

First Tracks Biotherapeutics (TRAXV) director receives RSUs and options after spin-off - Stock Titan

First Tracks Biotherapeutics (TRAX) 10K Form and Latest SEC Filings 2026 - MarketBeat

Barclays initiates First Tracks Biotherapeutics stock at Overweight By Investing.com - Investing.com Canada

Director at First Tracks Biotherapeutics (TRAXV) receives new equity grants - Stock Titan

symbol__ Stock Quote Price and Forecast - CNN

TRAX News Today | Why did First Tracks Biotherapeutics stock drop today? $TRAX - MarketBeat

First Tracks Biotherapeutics (TRAX) Stock Price, News & Analysis $TRAX - MarketBeat

UBS initiates First Tracks Biotherapeutics stock with buy rating By Investing.com - Investing.com Canada

AnaptysBio: 'Hold' As Spin-Off Shifts Pipeline To First Tracks Biotherapeutics (ANAB) - Seeking Alpha

TRAX | First Tracks Biotherapeutics, Inc. Institutional Ownership - Quiver Quantitative

AnaptysBio completes spin-off of First Tracks Biotherapeutics By Investing.com - Investing.com Australia

AnaptysBio Completes Spin-Off, Inks Separation and Two-Year Transition Services Deal With First Tracks - TradingView

News On First Tracks Biotherapeutics Inc. (TRAXV) Now Under TRAX - Moomoo

ROIV

$28.32

0.14%

RPRX

$50.44

0.48%

BNTX

$95.50

3.88%

INSM

$139.44

0.41%

RVMD

$147.21

0.47%

ONC

$297.49

0.12%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く